scispace - formally typeset
Journal ArticleDOI

Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota.

TLDR
It is shown that expression of transforming Ras in HC11 mouse mammary epithelial cells enhanced the activity of endogenous PLD, indicating a putative signalling cascade comprising Ras-->PLD1b-->PKC-iota--> PLD2.
Abstract
The activation of phospholipase D (PLD) by transforming Ras is well documented. Although two distinct PLD isoforms, PLD1 and PLD2, have been cloned from mammalian cells, it has remained unclear whether both isoenzymes are activated by Ras and, if this is the case, whether they are stimulated by a common mechanism. In the present study we show that expression of transforming Ras in HC11 mouse mammary epithelial cells enhanced the activity of endogenous PLD. Co-expression of Ras with either PLD1b or PLD2 resulted in elevated activities of both PLD isoenzymes in HC11 cells, indicating that transforming Ras was capable of activating both PLD isoforms in vivo. Ras-induced activation of PLD was resistant to the protein kinase C (PKC) inhibitor GF109203X, which preferentially affects conventional- and novel-type PKCs, but sensitive to Ro-31-8220, which inhibits atypical PKCs more effectively. Co-transfection of atypical PKC-iota with either PLD1b or PLD2 led to a selective activation of PLD2 by PKC-iota, whereas PLD1b was not affected. PLD1b, however, was found to be a potent activator of PKC-iota, whereas PLD2 was less effective in this respect. The data suggest that PKC-iota acts upstream of PLD2 and that PLD1b is implicated in the activation of PKC-iota. The data are discussed as indicating a putative signalling cascade comprising Ras-->PLD1b-->PKC-iota-->PLD2. Evidence for the implication of this pathway in the transcriptional regulation of cyclin D1 is also presented.

read more

Citations
More filters
Journal ArticleDOI

Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress

TL;DR: Results suggest that phosphorylation of Nrf2 Ser40 by aPKC(s) is involved in the nuclear translocation and ARE transactivation of NRF2 by oxidative stress.
Journal Article

Phospholipase D in cell proliferation and cancer.

TL;DR: Evidence is summarized implicating PLD as a critical regulator of cell proliferation, survival signaling, cell transformation, and tumor progression.
Journal ArticleDOI

Atypical Protein Kinase Cι Plays a Critical Role in Human Lung Cancer Cell Growth and Tumorigenicity

TL;DR: The data demonstrate that PKCι is a critical lung cancer gene that activates a Rac1→Pak→Mek1, 2→Erk1,2 signaling pathway required for transformed growth, and indicate thatPKCι may be an attractive molecular target for mechanism-based therapies for treatment of lung cancer.
Journal ArticleDOI

Protein kinase Cι: Human oncogene, prognostic marker and therapeutic target

TL;DR: How oncogenic PKCι signaling has been successfully targeted to identify a novel, mechanism-based therapeutic drug currently entering clinical trials for treatment of human lung cancer is discussed.
Journal ArticleDOI

Targeting the oncogenic protein kinase Cι signalling pathway for the treatment of cancer

TL;DR: This work has identified compounds that can disrupt PB1-PB1 domain interactions between PKCiota and the adaptor molecule Par6 that exhibit anti-tumour activity against NSCLC both in vitro and in vivo.
Related Papers (5)